Factors that guide selection among androgen receptor inhibitors in patients with nonmetastatic castration-resistant prostate cancer: Q&A

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	16-17
Number of pages	2
Journal	Clinical Advances in Hematology and Oncology
Volume	20
Issue number	5
State	Published - 1 May 2022

Cite this

@article{4ff75f3add2245138b38dd0333c6bdf4,

title = "Factors that guide selection among androgen receptor inhibitors in patients with nonmetastatic castration-resistant prostate cancer: Q&A",

author = "Oh, {William K.} and Rettig, {Matthew B.}",

year = "2022",

month = may,

day = "1",

language = "English",

volume = "20",

pages = "16--17",

journal = "Clinical Advances in Hematology and Oncology",

issn = "1543-0790",

publisher = "Millennium Medical Publishing, Inc.",

number = "5",

}

TY - JOUR

T1 - Factors that guide selection among androgen receptor inhibitors in patients with nonmetastatic castration-resistant prostate cancer

T2 - Q&A

AU - Oh, William K.

AU - Rettig, Matthew B.

PY - 2022/5/1

Y1 - 2022/5/1

UR - http://www.scopus.com/inward/record.url?scp=85130646393&partnerID=8YFLogxK

M3 - Article

C2 - 35579581

AN - SCOPUS:85130646393

SN - 1543-0790

VL - 20

SP - 16

EP - 17

JO - Clinical Advances in Hematology and Oncology

JF - Clinical Advances in Hematology and Oncology

IS - 5

ER -